HEADER APOPTOSIS 20-SEP-11 4A1U TITLE CRYSTAL STRUCTURE OF ALPHA-BETA-FOLDAMER 2C IN COMPLEX WITH BCL-XL COMPND MOL_ID: 1; COMPND 2 MOLECULE: BCL-2-LIKE PROTEIN 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 1-26,83-209; COMPND 5 SYNONYM: BCL-XL, BCL2-L-1, APOPTOSIS REGULATOR BCL-X; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: ALPHA-BETA-FOLDAMER 2C; COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PGEX; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 13 ORGANISM_TAXID: 32630 KEYWDS APOPTOSIS, ALPHA-HELIX, BH3, MIMICRY EXPDTA X-RAY DIFFRACTION AUTHOR M.D.BOERSMA,H.S.HAASE,K.J.KAUFMAN,W.S.HORNE,E.F.LEE,O.B.CLARKE, AUTHOR 2 B.J.SMITH,P.M.COLMAN,S.H.GELLMAN,W.D.FAIRLIE REVDAT 6 20-DEC-23 4A1U 1 REMARK REVDAT 5 15-NOV-23 4A1U 1 REMARK LINK ATOM REVDAT 4 10-JUL-19 4A1U 1 REMARK REVDAT 3 24-APR-19 4A1U 1 REMARK SEQRES LINK REVDAT 2 25-JAN-12 4A1U 1 JRNL REVDAT 1 28-DEC-11 4A1U 0 JRNL AUTH M.D.BOERSMA,H.S.HAASE,K.J.PETERSON-KAUFMAN,E.F.LEE, JRNL AUTH 2 O.B.CLARKE,P.M.COLMAN,B.J.SMITH,W.S.HORNE,W.D.FAIRLIE, JRNL AUTH 3 S.H.GELLMAN JRNL TITL EVALUATION OF DIVERSE ALPHA/BETA-BACKBONE PATTERNS FOR JRNL TITL 2 FUNCTIONAL ALPHA-HELIX MIMICRY: ANALOGUES OF THE BIM BH3 JRNL TITL 3 DOMAIN. JRNL REF J.AM.CHEM.SOC. V. 134 315 2012 JRNL REFN ISSN 0002-7863 JRNL PMID 22040025 JRNL DOI 10.1021/JA207148M REMARK 2 REMARK 2 RESOLUTION. 1.54 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.7.2_861) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.54 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.86 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 30977 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.172 REMARK 3 R VALUE (WORKING SET) : 0.171 REMARK 3 FREE R VALUE : 0.198 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1558 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 19.8630 - 3.4200 1.00 2891 145 0.1775 0.1824 REMARK 3 2 3.4200 - 2.7168 1.00 2754 138 0.1533 0.2079 REMARK 3 3 2.7168 - 2.3740 1.00 2699 150 0.1488 0.1688 REMARK 3 4 2.3740 - 2.1572 1.00 2729 138 0.1521 0.1955 REMARK 3 5 2.1572 - 2.0028 1.00 2685 154 0.1565 0.1928 REMARK 3 6 2.0028 - 1.8848 1.00 2659 153 0.1653 0.2028 REMARK 3 7 1.8848 - 1.7904 1.00 2686 132 0.1816 0.2196 REMARK 3 8 1.7904 - 1.7126 1.00 2681 126 0.1892 0.2217 REMARK 3 9 1.7126 - 1.6467 1.00 2641 163 0.2103 0.2486 REMARK 3 10 1.6467 - 1.5899 1.00 2683 126 0.2376 0.2771 REMARK 3 11 1.5899 - 1.5402 0.88 2311 133 0.2989 0.2842 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.86 REMARK 3 K_SOL : 0.40 REMARK 3 B_SOL : 60.36 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.310 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 17.460 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.92270 REMARK 3 B22 (A**2) : 1.92270 REMARK 3 B33 (A**2) : -3.84540 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 1483 REMARK 3 ANGLE : 1.327 2010 REMARK 3 CHIRALITY : 0.061 206 REMARK 3 PLANARITY : 0.006 261 REMARK 3 DIHEDRAL : 15.565 548 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -20.2856 10.1154 25.6249 REMARK 3 T TENSOR REMARK 3 T11: 0.0801 T22: 0.0444 REMARK 3 T33: 0.0755 T12: -0.0000 REMARK 3 T13: -0.0092 T23: -0.0019 REMARK 3 L TENSOR REMARK 3 L11: 1.2541 L22: 0.8090 REMARK 3 L33: 1.2493 L12: 0.1998 REMARK 3 L13: 0.2067 L23: 0.1304 REMARK 3 S TENSOR REMARK 3 S11: 0.1097 S12: -0.0910 S13: -0.1201 REMARK 3 S21: 0.1018 S22: -0.0517 S23: 0.0077 REMARK 3 S31: 0.0941 S32: -0.0840 S33: -0.0365 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4A1U COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-SEP-11. REMARK 100 THE DEPOSITION ID IS D_1290048903. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-DEC-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.953692 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30977 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.540 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 5.180 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.9400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.54 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.63 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.47 REMARK 200 R MERGE FOR SHELL (I) : 0.76000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.920 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER FOR MR REMARK 200 STARTING MODEL: PDB ENTRY 3FDL REMARK 200 REMARK 200 REMARK: MOLECULAR REPLACEMENT WAS PERFORMED USING THE STRUCTURE OF REMARK 200 BCL-XL FROM THE PDB ENTRY 3FDL, WITH THE PEPTIDE REMOVED, AS THE REMARK 200 SEARCH MODEL. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.99 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.56 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.5 M AMMONIUM SULPHATE, 0.1 M TRIS PH REMARK 280 8.5, 12% (V/V) GLYCEROL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 39.72267 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 79.44533 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 79.44533 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 39.72267 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2550 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10020 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -36.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2009 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -4 REMARK 465 PRO A -3 REMARK 465 LEU A -2 REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 GLN A 207 REMARK 465 GLU A 208 REMARK 465 ARG A 209 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLU A 202 CB CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2145 O HOH A 2146 2.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 B3A B 103 CA - C - N ANGL. DEV. = 29.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 106 155.61 129.28 REMARK 500 LEU A 112 -99.13 -67.79 REMARK 500 HIS A 113 126.92 108.01 REMARK 500 HR7 B 96 -84.05 -13.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 B3E B 93 LEU B 94 148.89 REMARK 500 ARG B 95 HR7 B 96 146.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 B3E B 93 -16.92 REMARK 500 B3E B 100 -15.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 1207 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1208 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 1209 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BXL RELATED DB: PDB REMARK 900 STRUCTURE OF BCL-XL/BAK PEPTIDE COMPLEX, NMR, MINIMIZED AVERAGE REMARK 900 STRUCTURE REMARK 900 RELATED ID: 4A1W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ALPHA-BETA FOLDAMER 4C IN COMPLEX WITH BCL-XL REMARK 900 RELATED ID: 1YSI RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL- XL INCOMPLEX REMARK 900 WITH AN ACYL-SULFONAMIDE-BASED LIGAND REMARK 900 RELATED ID: 2YJ1 RELATED DB: PDB REMARK 900 PUMA BH3 FOLDAMER IN COMPLEX WITH BCL-XL REMARK 900 RELATED ID: 2B48 RELATED DB: PDB REMARK 900 BCL-XL 3D DOMAIN SWAPPED DIMER REMARK 900 RELATED ID: 1R2E RELATED DB: PDB REMARK 900 HUMAN BCL-XL CONTAINING A GLU TO LEU MUTATION AT POSITION 92 REMARK 900 RELATED ID: 1YSN RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL- XLCOMPLEXED REMARK 900 WITH AN ACYL-SULFONAMIDE-BASED LIGAND REMARK 900 RELATED ID: 1YSG RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL- XL INCOMPLEX REMARK 900 WITH "SAR BY NMR" LIGANDS REMARK 900 RELATED ID: 1R2G RELATED DB: PDB REMARK 900 HUMAN BCL-XL CONTAINING A PHE TO TRP MUTATION AT POSITION 97 REMARK 900 RELATED ID: 1R2H RELATED DB: PDB REMARK 900 HUMAN BCL-XL CONTAINING AN ALA TO LEU MUTATION AT POSITION142 REMARK 900 RELATED ID: 1LXL RELATED DB: PDB REMARK 900 NMR STRUCTURE OF BCL-XL, AN INHIBITOR OF PROGRAMMED CELL DEATH, REMARK 900 MINIMIZED AVERAGE STRUCTURE REMARK 900 RELATED ID: 1R2D RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN BCL-XL AT 1.95 ANGSTROMS REMARK 900 RELATED ID: 1G5J RELATED DB: PDB REMARK 900 COMPLEX OF BCL-XL WITH PEPTIDE FROM BAD REMARK 900 RELATED ID: 1MAZ RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF BCL-XL, AN INHIBITOR OF PROGRAMMED CELL DEATH REMARK 900 RELATED ID: 1R2I RELATED DB: PDB REMARK 900 HUMAN BCL-XL CONTAINING A PHE TO LEU MUTATION AT POSITION 146 REMARK 999 REMARK 999 SEQUENCE REMARK 999 DELETION OF AMINO ACID RESIDUES 27-82 AND 210-233 DBREF 4A1U A 1 26 UNP Q07817 B2CL1_HUMAN 1 26 DBREF 4A1U A 83 209 UNP Q07817 B2CL1_HUMAN 83 209 DBREF 4A1U B 87 106 PDB 4A1U 4A1U 87 106 SEQADV 4A1U GLY A -4 UNP Q07817 EXPRESSION TAG SEQADV 4A1U PRO A -3 UNP Q07817 EXPRESSION TAG SEQADV 4A1U LEU A -2 UNP Q07817 EXPRESSION TAG SEQADV 4A1U GLY A -1 UNP Q07817 EXPRESSION TAG SEQADV 4A1U SER A 0 UNP Q07817 EXPRESSION TAG SEQRES 1 A 158 GLY PRO LEU GLY SER MET SER GLN SER ASN ARG GLU LEU SEQRES 2 A 158 VAL VAL ASP PHE LEU SER TYR LYS LEU SER GLN LYS GLY SEQRES 3 A 158 TYR SER TRP SER GLN MET ALA ALA VAL LYS GLN ALA LEU SEQRES 4 A 158 ARG GLU ALA GLY ASP GLU PHE GLU LEU ARG TYR ARG ARG SEQRES 5 A 158 ALA PHE SER ASP LEU THR SER GLN LEU HIS ILE THR PRO SEQRES 6 A 158 GLY THR ALA TYR GLN SER PHE GLU GLN VAL VAL ASN GLU SEQRES 7 A 158 LEU PHE ARG ASP GLY VAL ASN TRP GLY ARG ILE VAL ALA SEQRES 8 A 158 PHE PHE SER PHE GLY GLY ALA LEU CYS VAL GLU SER VAL SEQRES 9 A 158 ASP LYS GLU MET GLN VAL LEU VAL SER ARG ILE ALA ALA SEQRES 10 A 158 TRP MET ALA THR TYR LEU ASN ASP HIS LEU GLU PRO TRP SEQRES 11 A 158 ILE GLN GLU ASN GLY GLY TRP ASP THR PHE VAL GLU LEU SEQRES 12 A 158 TYR GLY ASN ASN ALA ALA ALA GLU SER ARG LYS GLY GLN SEQRES 13 A 158 GLU ARG SEQRES 1 B 20 ACE ILE HT7 ILE ALA GLN B3E LEU ARG HR7 ILE GLY ASP SEQRES 2 B 20 B3E PHE ASN B3A TYR TYR NH2 MODRES 4A1U HT7 B 89 TRP MODRES 4A1U B3E B 93 GLU (3S)-3-AMINOHEXANEDIOIC ACID MODRES 4A1U HR7 B 96 ARG MODRES 4A1U B3E B 100 GLU (3S)-3-AMINOHEXANEDIOIC ACID MODRES 4A1U B3A B 103 ALA (3S)-3-AMINOBUTANOIC ACID HET ACE B 87 6 HET HT7 B 89 27 HET B3E B 93 18 HET HR7 B 96 27 HET B3E B 100 18 HET B3A B 103 13 HET NH2 B 106 3 HET CL A1207 1 HET SO4 A1208 5 HET CL A1209 1 HETNAM ACE ACETYL GROUP HETNAM HT7 (3S)-3-AMINO-4-(1H-INDOL-3-YL)BUTANOIC ACID HETNAM B3E (3S)-3-AMINOHEXANEDIOIC ACID HETNAM HR7 (3S)-3-AMINO-6-[(DIAMINOMETHYLIDENE)AMINO]HEXANOIC ACID HETNAM B3A (3S)-3-AMINOBUTANOIC ACID HETNAM NH2 AMINO GROUP HETNAM CL CHLORIDE ION HETNAM SO4 SULFATE ION HETSYN HT7 BETA-HOMOTRYPTOPHAN HETSYN HR7 BETA-HOMOARGININE FORMUL 2 ACE C2 H4 O FORMUL 2 HT7 C12 H14 N2 O2 FORMUL 2 B3E 2(C6 H11 N O4) FORMUL 2 HR7 C7 H16 N4 O2 FORMUL 2 B3A C4 H9 N O2 FORMUL 2 NH2 H2 N FORMUL 3 CL 2(CL 1-) FORMUL 4 SO4 O4 S 2- FORMUL 6 HOH *196(H2 O) HELIX 1 1 MET A 1 GLN A 19 1 19 HELIX 2 2 SER A 25 PHE A 105 1 25 HELIX 3 3 LEU A 108 LEU A 112 5 5 HELIX 4 4 THR A 118 PHE A 131 1 14 HELIX 5 5 ASN A 136 LYS A 157 1 22 HELIX 6 6 MET A 159 VAL A 161 5 3 HELIX 7 7 LEU A 162 LEU A 178 1 17 HELIX 8 8 LEU A 178 GLN A 183 1 6 HELIX 9 9 GLY A 186 GLY A 196 1 11 HELIX 10 10 ASN A 198 GLY A 206 1 9 LINK C ACE B 87 N ILE B 88 1555 1555 1.33 LINK C ILE B 88 N HT7 B 89 1555 1555 1.33 LINK C HT7 B 89 N ILE B 90 1555 1555 1.33 LINK C GLN B 92 N B3E B 93 1555 1555 1.33 LINK C B3E B 93 N LEU B 94 1555 1555 1.34 LINK C ARG B 95 N HR7 B 96 1555 1555 1.33 LINK C HR7 B 96 N ILE B 97 1555 1555 1.32 LINK C ASP B 99 N B3E B 100 1555 1555 1.32 LINK C B3E B 100 N PHE B 101 1555 1555 1.33 LINK C ASN B 102 N B3A B 103 1555 1555 1.33 LINK C B3A B 103 N TYR B 104 1555 1555 1.33 LINK C TYR B 105 N NH2 B 106 1555 1555 1.33 SITE 1 AC1 1 GLN A 26 SITE 1 AC2 3 LEU A 99 ARG A 103 ARG A 204 SITE 1 AC3 3 ARG A 102 HOH A2082 HOH A2113 CRYST1 54.706 54.706 119.168 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018280 0.010554 0.000000 0.00000 SCALE2 0.000000 0.021107 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008392 0.00000